Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs
Open accessThe DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Abstract
IFITMs are broad antiviral factors that block incoming virions in endosomal vesicles, protecting target cells from infection. In the case of HIV-1, we and others reported the existence of an additional antiviral mechanism through which IFITMs lead to the production of virions of reduced infectivity. However, whether this second mechanism of inhibition is unique to HIV or extends to other viruses is currently unknown. To address this question, we have analyzed the susceptibility of a broad spectrum of viruses to the negative imprinting of the virion particles infectivity by IFITMs. The results we have gathered indicate that this second antiviral property of IFITMs extends well beyond HIV and we were able to identify viruses susceptible to the three IFITMs altogether (HIV-1, SIV, MLV, MPMV, VSV, MeV, EBOV, WNV), as well as viruses that displayed a member-specific susceptibility (EBV, DUGV), or were resistant to all IFITMs (HCV, RVFV, MOPV, AAV). The swapping of genetic elements between resistant and susceptible viruses allowed us to point to specificities in the viral mode of assembly, rather than glycoproteins as dominant factors of susceptibility. However, we also show that, contrarily to X4-, R5-tropic HIV-1 envelopes confer resistance against IFITM3, suggesting that viral receptors add an additional layer of complexity in the IFITMs-HIV interplay. Lastly, we show that the overall antiviral effects ascribed to IFITMs during spreading infections, are the result of a bimodal inhibition in which IFITMs act both by protecting target cells from incoming viruses and in driving the production of virions of reduced infectivity. Overall, our study reports for the first time that the negative imprinting of the virion particles infectivity is a conserved antiviral property of IFITMs and establishes IFITMs as a paradigm of restriction factor capable of interfering with two distinct phases of a virus life cycle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IFITM proteins are broad antiviral factors that inhibit viral entry and exit for HIV-1, SIV, MLV, VSV, EBOV, WNV, among other viruses69.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [69]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A diverse range of gene products are effectors of the type I interferon antiviral response
Schoggins, J. W., Wilson, S. J., Panis, M., Murphy, M. Y., Jones, C. T., Bieniasz, P., & Rice, C. M. (2011) · Nature · doi:10.1038/nature09907 · Cited by 2,433
Keele, B. F., Giorgi, E. E., Salazar-Gonzalez, J. F., Decker, J. M., Pham, K. T., Salazar, M. G., Sun, C., Grayson, T., Wang, S., Li, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802203105 · Cited by 1,912
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M. (2011) · Nature · doi:10.1038/nature10117 · Cited by 1,511 · cited 1×
“This trick allows a very efficient transduction of myeloid cells by HIV-1 [88] [89] [90] thanks to the reported ability of Vpx to remove the restriction factor SAMHD1 [91, 92] .”
BackgroundTsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding
Garrus, J. E., von Schwedler, U. K., Pornillos, O. W., Morham, S. G., Zavitz, K. H., Wang, H. E., Wettstein, D. A., Stray, K. M., Côté, M., Rich, R. L., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00506-2 · Cited by 1,369 · cited 1×
“These results are intriguing because MLV and especially MPMV display assembly specificities that are distinct from lentiviruses, although they ultimately acquire a plasma membrane-derived envelope [56, 57, 58] .”
ResultBrass, A. L., Huang, I.-C., Benita, Y., John, S. P., Krishnan, M. N., Feeley, E. M., Ryan, B. J., Weyer, J. L., van der Weyden, L., Fikrig, E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.12.017 · Cited by 1,269
Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M. P., & Skowronski, J. (2011) · Nature · doi:10.1038/nature10195 · Cited by 1,200 · cited 1×
“This trick allows a very efficient transduction of myeloid cells by HIV-1 [88] [89] [90] thanks to the reported ability of Vpx to remove the restriction factor SAMHD1 [91, 92] .”
BackgroundInfectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes
Bartosch, B., Dubuisson, J., & Cosset, F.-L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021756 · Cited by 1,111
IFITM3 restricts the morbidity and mortality associated with influenza
The GenISIS Investigators, Everitt, A. R., The MOSAIC Investigators, Clare, S., Pertel, T., John, S. P., Wash, R. S., Smith, S. E., Chin, C. R., Feeley, E. M., et al. (2012) · Nature · doi:10.1038/nature10921 · Cited by 782
Friedman, R. L., Manly, S. P., McMahon, M., Kerr, I. M., & Stark, G. R. (1984) · Cell · doi:10.1016/0092-8674(84)90270-8 · Cited by 718
HIV Enters Cells via Endocytosis and Dynamin-Dependent Fusion with Endosomes
Miyauchi, K., Kim, Y., Latinovic, O., Morozov, V., & Melikyan, G. B. (2009) · Cell · doi:10.1016/j.cell.2009.02.046 · Cited by 681
Research works printed but not linked: 3
- R Jia, 2014, Identification of an endocytic signal essential for the antiviral action of IFITM3, Cell Microbiol
- NM Chesarino, 2014, Phosphorylation of the Antiviral Protein IFITM3 Dually Regulates its Endocytosis and Ubiquitination, J Biol Chem
- X Zhu, 2014, IFITM3-containing exosome as a novel mediator for anti-viral response in dengue virus infection, Cell Microbiol
Cited by
IFITM Genes, Variants, and Their Roles in the Control and Pathogenesis of Viral Infections
Zhao, X., Li, J., Winkler, C. A., An, P., & Guo, J. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03228 · Cited by 164
IFITM proteins: Understanding their diverse roles in viral infection, cancer, and immunity
Gómez-Herranz, M., Taylor, J., & Sloan, R. D. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102741 · Cited by 131
Shi, G., Schwartz, O., & Compton, A. A. (2017) · Retrovirology · doi:10.1186/s12977-017-0377-y · Cited by 109
Chemudupati, M., Kenney, A. D., Bonifati, S., Zani, A., McMichael, T. M., Wu, L. J., & Yount, J. S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.09.012 · Cited by 102
Guo, X., Steinkühler, J., Marin, M., Li, X., Lu, W., Dimova, R., & Melikyan, G. B. (2021) · ACS Nano · doi:10.1021/acsnano.0c10567 · Cited by 96
Metadata
- Authors
- Tartour, K., Nguyen, X.-N., Appourchaux, R., Assil, S., Barateau, V., Bloyet, L.-M., Burlaud Gaillard, J., Confort, M.-P., Escudero-Perez, B., Gruffat, H., Hong, S. S., Moroso, M., Reynard, O., Reynard, S., Decembre, E., Ftaich, N., Rossi, A., Wu, N., Arnaud, F., Baize, S., Dreux, M., Gerlier, D., Paranhos-Baccala, G., Volchkov, V., Roingeard, P., & Cimarelli, A.
- Affiliations
- Lyon 1 Université (FR)
- Université de Tours (FR)
- Corresponding author
- Cimarelli, Andrea
- ORCID
- Assil, Sonia
- Barateau, Véronique
- Bloyet, Louis-Marie
- Confort, Marie-Pierre
- Gruffat, Henri
- Hong, Saw See
- Moroso, Marie
- Reynard, Olivier
- Reynard, Stéphanie
- Rossi, Axel
- Wu, Nannan
- Arnaud, Frédérick
- Baize, Sylvain
- Dreux, Marlène
- Gerlier, Denis
- Paranhos-Baccala, Glaucia
- Volchkov, Viktor
- Roingeard, Philippe
- Cimarelli, Andrea
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-09-28
- Volume
- 13
- Issue
- 9
- Pages
- e1006610
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC5619827
- OpenAlex
- W2759331290
- Cited by
- 69
- References
- 93
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 10 · 2023: 6 · 2022: 5 · 2021: 14 · 2020: 8 · 2019: 7 · 2018: 10 · 2017: 1
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- HAL (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Fondation Innovations en Infectiologie
- Sidaction
- Agence Nationale de la Recherche (ANR-14-EBOL-0002)
- Deutsches Primatenzentrum
- Institut National de la Recherche Agronomique
- Université de Lyon
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- interferon-induced transmembrane proteins, IFITM3, HIV-1, viral infectivity, viral assembly, host restriction factors, viral receptor, viral replication inhibition, broad-spectrum antiviral activity
- MeSH terms
- Antigens, Differentiation, Cell Line, Humans, Virion, Virus Replication, HIV-1, Virus Internalization, Host-Pathogen Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs. https://app.cochat.ai/papers/10.1371/journal.ppat.1006610
- The paper
- Tartour, K., Nguyen, X.-N., Appourchaux, R., Assil, S., Barateau, V., Bloyet, L.-M., Burlaud Gaillard, J., Confort, M.-P., Escudero-Perez, B., Gruffat, H., Hong, S. S., Moroso, M., Reynard, O., Reynard, S., Decembre, E., Ftaich, N., Rossi, A., Wu, N., Arnaud, F., . . . Cimarelli, A. (2017). Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1006610
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.